U.S. FDA approves ChemoCentryx drug to treat rare autoimmune disease

Churchill Capital XI

08/10/2021 12:05

Oct 8 (Reuters) - The U.S. Food and Drug Administration on
Friday approved ChemoCentryx Inc's  CCXI.O  lead drug candidate,
Avacopan, for treating a rare, fatal autoimmune disease, the
biopharmaceutical company said.

 (Reporting by Oishee Majumdar and Dania Nadeem in Bengaluru;
Editing by Anil D'Silva)
 ((oishee.majumdar@thomsonreuters.com;))